These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3234192)

  • 1. Correlation between NMR scans of extraocular muscles and clinical symptoms in Graves' ophthalmopathy.
    Troelstra A; Rijneveld WJ; Kooijman AC; Houtman WA
    Doc Ophthalmol; 1988; 70(2-3):243-9. PubMed ID: 3234192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative analysis of orbital soft tissue in Graves' disease based on B-mode ultrasonography.
    Yamamoto K; Itoh K; Yoshida S; Saito K; Sakamoto Y; Matsuda A; Saito T; Kuzuya T
    Endocrinol Jpn; 1979 Apr; 26(2):255-61. PubMed ID: 582582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L; Norberg R
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The measurement of change in Graves' ophthalmopathy.
    Gorman CA
    Thyroid; 1998 Jun; 8(6):539-43. PubMed ID: 9669294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves' ophthalmopathy: V. Aetiology of upper eyelid retraction in Graves' ophthalmopathy.
    Feldon SE; Levin L
    Br J Ophthalmol; 1990 Aug; 74(8):484-5. PubMed ID: 2390525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
    Antoniazzi F; Zamboni G; Cerini R; Lauriola S; Dall'Agnola A; Tatò L
    J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' ophthalmopathy: I. Simple CT estimates of extraocular muscle volume.
    Hallin ES; Feldon SE
    Br J Ophthalmol; 1988 Sep; 72(9):674-7. PubMed ID: 3179254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy.
    Feldon SE; Lee CP; Muramatsu SK; Weiner JM
    Arch Ophthalmol; 1985 Feb; 103(2):213-5. PubMed ID: 3838463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.
    Nishikawa M; Yoshimura M; Toyoda N; Masaki H; Yonemoto T; Gondou A; Kato T; Kurokawa H; Furumura T; Inada M
    Acta Endocrinol (Copenh); 1993 Sep; 129(3):213-9. PubMed ID: 8105634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.
    Villadolid MC; Yokoyama N; Izumi M; Nishikawa T; Kimura H; Ashizawa K; Kiriyama T; Uetani M; Nagataki S
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2830-3. PubMed ID: 7673432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' ophthalmopathy: II. Correlation of clinical signs with measures derived from computed tomography.
    Hallin ES; Feldon SE
    Br J Ophthalmol; 1988 Sep; 72(9):678-82. PubMed ID: 3179255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?
    Szucs-Farkas Z; Toth J; Balazs E; Galuska L; Burman KD; Karanyi Z; Leovey A; Nagy EV
    AJR Am J Roentgenol; 2002 Oct; 179(4):1005-10. PubMed ID: 12239055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking.
    Szucs-Farkas Z; Toth J; Kollar J; Galuska L; Burman KD; Boda J; Leovey A; Varga J; Ujhelyi B; Szabo J; Berta A; Nagy EV
    Thyroid; 2005 Feb; 15(2):146-51. PubMed ID: 15753674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Mar; 121(3):284-90. PubMed ID: 8597271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of extraocular muscle volumes in Graves' ophthalmopathy: a quantitative computed tomography study.
    Feldon SE; Weiner JM
    Arch Ophthalmol; 1982 Aug; 100(8):1266-9. PubMed ID: 6896638
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy.
    Kahaly G; Diaz M; Just M; Beyer J; Lieb W
    Thyroid; 1995 Apr; 5(2):107-11. PubMed ID: 7647569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
    Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
    Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema.
    Chang CC; Chang TC; Kao SC; Kuo YF; Chien LF
    Acta Endocrinol (Copenh); 1993 Oct; 129(4):322-7. PubMed ID: 8237250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inferior oblique muscle biopsy in Graves' ophthalmopathy.
    Hoogenraad TU; Tan KE
    J R Soc Med; 1989 Sep; 82(9):571. PubMed ID: 2795584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.